Recursion Pharmaceuticals/$RXRX
1D1W1MYTD1Y5YMAX
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.
- Ticker
- $RXRX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 600
- Headquarters
- Salt Lake City, United States
- Website
- www.recursion.com
RXRX Metrics
BasicAdvanced
$1.8B
-
-$1.02
1.05
-
Price and volume
Market cap
$1.8B
Beta
1.05
52-week high
$7.18
52-week low
$2.77
Average daily volume
16M
Financial strength
Current ratio
5.034
Quick ratio
4.672
Long term debt to equity
4.803
Total debt to equity
7.283
Interest coverage (TTM)
-371.35%
Profitability
EBITDA (TTM)
-471.604
Gross margin (TTM)
-715.69%
Net profit margin (TTM)
-945.90%
Operating margin (TTM)
-1,002.56%
Effective tax rate (TTM)
0.88%
Revenue per employee (TTM)
$90,000
Management effectiveness
Return on assets (TTM)
-27.33%
Return on equity (TTM)
-56.58%
Valuation
Price to revenue (TTM)
30.916
Price to book
1.95
Price to tangible book (TTM)
3.79
Price to free cash flow (TTM)
-4.787
Free cash flow yield (TTM)
-20.89%
Free cash flow per share (TTM)
-0.698
Growth
Revenue change (TTM)
-15.08%
Earnings per share change (TTM)
-43.36%
3-year revenue growth (CAGR)
3.15%
3-year earnings per share growth (CAGR)
-9.39%
What the Analysts think about RXRX
Analyst ratings (Buy, Hold, Sell) for Recursion Pharmaceuticals stock.
RXRX Financial Performance
Revenues and expenses
RXRX Earnings Performance
Company profitability
RXRX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.